Download PDF
Neuropediatrics
DOI: 10.1055/a-2579-6247
Original Article

MOG-Encephalitis is the Most Prevalent Autoimmune Encephalitis in Children: MERIN Study Data on Encephalitis

Ruth Helena Fellmeth
1   Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany
,
Lampros Kousoulos
1   Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany
,
George Christoph Korenke
2   Department of Neuropediatrics, University Children's Hospital, Klinikum Oldenburg, Oldenburg, Germany
,
Hans-Jürgen Christen
3   Department of Pediatrics, Children's Hospital auf der Bult, Hannover, Germany
,
Masyar Monazahian
4   Governmental Institute of Public Health of Lower Saxony (NLGA), Hannover, Germany
,
Justine Dargvainiene
5   Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel/Lübeck, Germany
,
Klaus-Peter Wandinger
5   Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel/Lübeck, Germany
6   Department of Neurology, University Hospital Schleswig-Holstein, Lübeck, Germany
,
Frank Leypoldt
5   Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel/Lübeck, Germany
7   Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany
,
Kevin Rostásy
1   Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany
› Author Affiliations
Funding The preparation of this study and the research presented herein were supported in part by grants from the German Federal Ministry of Education and Research (CONNECT-GENERATE grant no. 01GM1908A and 01GM2208A).
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction

Encephalitis in children is a serious inflammatory brain disease caused by infectious or autoimmune-mediated processes. The frequency of autoimmune variants in pediatric populations is not entirely clear.

Aim

To study the frequency of myelin oligodendrocyte glycoprotein (MOG) antibody (ab)-mediated autoimmune encephalitis (AE) in children included in the Meningitis/Encephalitis register of Lower Saxony (MERIN).

Methods

Medical records of 1,341 children treated between 2011 and 2020 in two large children's hospitals participating in a prospective study on encephalitis (MERIN) were reviewed. Children meeting diagnostic criteria for possible AE were finally included if serum samples and informed re-consent were available. Children with pathogen-mediated encephalitis were also included as controls. All available serum samples were tested for MOG- and anti-N-methyl-D-aspartate receptor (NMDAR) antibodies (abs) using cell- and tissue-based assay (TBA).

Results

We included 55 children of whom 16 had pathogen-associated meningoencephalitis. Thirty-nine out of fifty-five children were classified as possible AE and 3/39 fulfilled the criteria for MOG ab-associated disease (MOGAD). No patients' sera harbored NMDAR abs. However, 5/39 patients fulfilled the criteria for probable, auto-ab-negative AE.

Conclusion

In line with recent research our study suggests that ab-mediated AE and probable ab-negative AE are rare in children. The existing criteria seem suitable for identifying patients with AE but should include the testing of serum MOG abs. Further yet unknown abs may play a role in children with AE.

Keywords

autoimmune encephalitis - myelin-oligodendrocyte glycoprotein - antibodies - children

Authors' Contributions

K.R. designed the study. R.F. and K.R. consulted the literature, wrote the manuscript, and made the tables. K.R., R.F., L.K., H.-J.C., and G.-C.K. collected the clinical data of the patients. F.L., J.D., and K.-P.W. made antibody testing. All authors contributed to editorial changes in the manuscript, and read, and approved the final manuscript.




Publication History

Received: 28 January 2025

Accepted: 09 April 2025

Accepted Manuscript online:
10 April 2025

Article published online:
16 May 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med 2018; 378 (09) 840-851
    Search in Google Scholar
  • 2 Graus F, Titulaer MJ, Balu R. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15 (04) 391-404
    Search in Google Scholar
  • 3 Tunkel AR, Glaser CA, Bloch KC. et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47 (03) 303-327
    Search in Google Scholar
  • 4 Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012; 27 (11) 1460-1469
    Search in Google Scholar
  • 5 Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis–relevance for clinical practice and hippocampal function. Neuroscience 2015; 309: 68-83
    Search in Google Scholar
  • 6 Venkatesan A, Tunkel AR, Bloch KC. et al; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57 (08) 1114-1128
    Search in Google Scholar
  • 7 Messacar K, Fischer M, Dominguez SR, Tyler KL, Abzug MJ. Encephalitis in US children. Infect Dis Clin North Am 2018; 32 (01) 145-162
    Search in Google Scholar
  • 8 Erickson TA, Muscal E, Munoz FM. et al. Infectious and autoimmune causes of encephalitis in children. Pediatrics 2020; 145 (06) e20192543
    Search in Google Scholar
  • 9 Cellucci T, Van Mater H, Graus F. et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient. Neurol Neuroimmunol Neuroinflamm 2020; 7 (02) e663
    Search in Google Scholar
  • 10 Granerod J, Ambrose HE, Davies NWS. et al; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10 (12) 835-844
    Search in Google Scholar
  • 11 de Bruijn MAAM, Bruijstens AL, Bastiaansen AEM. et al; CHANCE Study Group. Pediatric autoimmune encephalitis: Recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm 2020; 7 (03) e682
    Search in Google Scholar
  • 12 Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10 (01) 63-74
    Search in Google Scholar
  • 13 Dalmau J, Armangué T, Planagumà J. et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 2019; 18 (11) 1045-1057
    Search in Google Scholar
  • 14 Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67 (04) 470-478
    Search in Google Scholar
  • 15 Armangue T, Olivé-Cirera G, Martínez-Hernandez E. et al; Spanish Pediatric anti-MOG Study Group. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 2020; 19 (03) 234-246
    Search in Google Scholar
  • 16 Banwell B, Bennett JL, Marignier R. et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 2023; 22 (03) 268-282
    Search in Google Scholar
  • 17 Łuczyńska A, Beyrer K, Holle I. et al. Evaluation of 17 years of MERIN (Meningitis and Encephalitis register in Lower Saxony, Germany) surveillance system: participants acceptability survey, completeness and timeliness of data. BMC Health Serv Res 2024; 24 (01) 59
    Search in Google Scholar
  • 18 Martinez-Hernandez E, Sepulveda M, Rostásy K. et al. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. JAMA Neurol 2015; 72 (02) 187-193
    Search in Google Scholar
  • 19 Wegener-Panzer A, Cleaveland R, Wendel EM. et al. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies. Neurol Neuroimmunol Neuroinflamm 2020; 7 (04) e731
    Search in Google Scholar
  • 20 Bruijstens AL, Lechner C, Flet-Berliac L. et al; E.U. paediatric MOG consortium. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 2020; 29: 2-13
    Search in Google Scholar
  • 21 Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54 (07) 899-904
    Search in Google Scholar
  • 22 Chen LW, Guasp M, Olivé-Cirera G. et al. Antibody investigations in 2,750 children with suspected autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2023; 11 (01) e200182
    Search in Google Scholar
  • 23 Titulaer MJ, McCracken L, Gabilondo I. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12 (02) 157-165
    Search in Google Scholar
  • 24 Hennes EM, Baumann M, Lechner C, Rostásy K. MOG spectrum disorders and role of MOG-antibodies in clinical practice. Neuropediatrics 2018; 49 (01) 3-11
    Search in Google Scholar
  • 25 Hacohen Y, Wright S, Waters P. et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013; 84 (07) 748-755
    Search in Google Scholar
  • 26 Ramanathan S, Brilot F, Irani SR, Dale RC. Origins and immunopathogenesis of autoimmune central nervous system disorders. Nat Rev Neurol 2023; 19 (03) 172-190
    Search in Google Scholar
  • 27 Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother 2015; 15 (12) 1391-1419
    Search in Google Scholar
  • 28 Haberlandt E, Bast T, Ebner A. et al. Limbic encephalitis in children and adolescents. Arch Dis Child 2011; 96 (02) 186-191
    Search in Google Scholar
  • 29 Mishra N, Rodan LH, Nita DA, Gresa-Arribas N, Kobayashi J, Benseler SM. Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases. J Child Neurol 2014; 29 (05) 677-683
    Search in Google Scholar
  • 30 Sabanathan S, Abdel-Mannan O, Mankad K. et al. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: a multicenter study. Ann Clin Transl Neurol 2022; 9 (01) 67-78
    Search in Google Scholar
  • 31 Graus F, Saiz A, Dalmau J. GAD antibodies in neurological disorders - insights and challenges. Nat Rev Neurol 2020; 16 (07) 353-365
    Search in Google Scholar
  • 32 Irani SR, Alexander S, Waters P. et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133 (09) 2734-2748
    Search in Google Scholar
  • 33 Wu L, Cai F, Zhuo Z. et al. CASPR2 antibody associated neurological syndromes in children. Sci Rep 2023; 13 (01) 2073
    Search in Google Scholar
  • 34 Syrbe S, Stettner GM, Bally J. et al. CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension. Neurology 2020; 94 (22) e2290-e2301
    Search in Google Scholar
  • 35 Liao D, Zhu S, Yang L. et al. Clinical characteristics and long-term outcome of CASPR2 antibody-associated autoimmune encephalitis in children. Ital J Pediatr 2024; 50 (01) 158
    Search in Google Scholar
  • 36 Fang B, McKeon A, Hinson SR. et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 2016; 73 (11) 1297-1307
    Search in Google Scholar
  • 37 Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol 2018; 9: 2802
    Search in Google Scholar
  • 38 Dalmau J, Graus F. Autoimmune encephalitis-misdiagnosis, misconceptions, and how to avoid them. JAMA Neurol 2023; 80 (01) 12-14
    Search in Google Scholar
  • 39 George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One 2014; 9 (09) e104169
    Search in Google Scholar